Article Details

Eligibility and Safety Considerations for Antiamyloid Alzheimer Therapies - Neurology live

Retrieved on: 2025-09-09 12:09:24

Tags for this article:

Click the tags to see associated articles and topics

Eligibility and Safety Considerations for Antiamyloid Alzheimer Therapies - Neurology live. View article details on hiswai:

Excerpt

The class is called antiamyloid monoclonal antibodies, but lecanemab targets primarily protofibril amyloid as well as plaque, whereas donanemab ...

Article found on: www.neurologylive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo